Hernandez-Aguado, J.J.; Sánchez Torres, D.Á.; Martínez Lamela, E.; Aguión Gálvez, G.; Sanz Espinosa, E.; Pérez Quintanilla, A.; Martínez-Carrillo, D.A.; Ramírez Mena, M.; Coronado Martín, P.J.; Zapardiel, I.;
et al. Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain). Vaccines 2022, 10, 387.
https://doi.org/10.3390/vaccines10030387
AMA Style
Hernandez-Aguado JJ, Sánchez Torres DÁ, Martínez Lamela E, Aguión Gálvez G, Sanz Espinosa E, Pérez Quintanilla A, Martínez-Carrillo DA, Ramírez Mena M, Coronado Martín PJ, Zapardiel I,
et al. Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain). Vaccines. 2022; 10(3):387.
https://doi.org/10.3390/vaccines10030387
Chicago/Turabian Style
Hernandez-Aguado, Juan J., Damián Ángel Sánchez Torres, Esther Martínez Lamela, Gema Aguión Gálvez, Eva Sanz Espinosa, Almudena Pérez Quintanilla, Daniela A. Martínez-Carrillo, Mar Ramírez Mena, Pluvio J. Coronado Martín, Ignacio Zapardiel,
and et al. 2022. "Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain)" Vaccines 10, no. 3: 387.
https://doi.org/10.3390/vaccines10030387
APA Style
Hernandez-Aguado, J. J., Sánchez Torres, D. Á., Martínez Lamela, E., Aguión Gálvez, G., Sanz Espinosa, E., Pérez Quintanilla, A., Martínez-Carrillo, D. A., Ramírez Mena, M., Coronado Martín, P. J., Zapardiel, I., & de la Fuente-Valero, J.
(2022). Quadrivalent Human Papillomavirus Vaccine Effectiveness after 12 Years in Madrid (Spain). Vaccines, 10(3), 387.
https://doi.org/10.3390/vaccines10030387
